Rivarospire 20 Mg 28 Tablets

Rivarospire 20 Mg 28 Tablets

Description:

Rivarospire 20 mg 28 tablets is a prescription oral anticoagulant (blood thinner) containing rivaroxaban, a direct factor Xa inhibitor. It is used to prevent and treat harmful blood clots and to reduce the risk of stroke and systemic embolism in specific high‑risk patients. By selectively blocking factor Xa in the coagulation cascade, Rivarospire helps prevent the formation of new clots and the growth of existing clots, supporting cardiovascular health and reducing the risk of life‑threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE). This medicine is intended for adult use under medical supervision.

Indications:

• Prevention of stroke and systemic embolism in adult patients with non‑valvular atrial fibrillation who have one or more risk factors (e.g., heart failure, hypertension, age ≥75 years, diabetes, prior stroke or transient ischemic attack).
• Treatment of deep vein thrombosis (DVT) in adults.
• Treatment of pulmonary embolism (PE) in adults.
• Prevention of recurrent DVT and PE after initial treatment.
• Prevention and treatment of blood clots in certain high‑risk patients as determined by a physician.
• Helps reduce symptoms and complications associated with blood clots, such as leg pain and swelling in DVT and shortness of breath or chest pain in PE (when used as part of a full treatment plan).

Active Ingredients / Key Components:

• Rivaroxaban – 20 mg per film‑coated tablet.
• Inactive ingredients (excipients): Full excipient list is not available in the provided information. Typical excipients in film‑coated tablets may include fillers, binders, disintegrants, and coating agents, but exact components and concentrations are not specified.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not change the dose or stop taking the medicine without medical advice.
• Usual adult dose for non‑valvular atrial fibrillation (stroke prevention): commonly 20 mg once daily, preferably taken with food. The exact dose and timing must be determined by your doctor based on kidney function and overall health.
• Usual adult dose for treatment of DVT and PE and prevention of recurrence: dosing regimen and duration are determined by the physician according to the treatment phase and patient risk profile. Follow your doctor’s instructions carefully.
• Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless your doctor or pharmacist specifically advises otherwise.
• Take at the same time each day to maintain consistent blood levels and anticoagulant effect.
• If you miss a dose: Take it as soon as you remember on the same day. Do not take a double dose to make up for a missed dose. Follow your doctor’s specific advice for missed doses.
• With food: The 20 mg strength should generally be taken with food to ensure optimal absorption, unless your doctor instructs otherwise.
• Duration of therapy: Depends on your medical condition (e.g., long‑term for atrial fibrillation or limited duration for DVT/PE). Only your doctor can decide how long you should continue treatment.

Clinical Benefits:

• Effectively reduces the risk of stroke and systemic embolism in patients with non‑valvular atrial fibrillation.
• Treats existing deep vein thrombosis (DVT) and pulmonary embolism (PE) and helps prevent the formation of new clots.
• Decreases the likelihood of recurrent DVT and PE after initial treatment, supporting long‑term vascular health.
• Provides predictable anticoagulant effect through direct factor Xa inhibition, reducing the need for routine coagulation monitoring in many patients (as per physician assessment).

Warnings & Contraindications:

• Do not use Rivarospire if you are allergic (hypersensitive) to rivaroxaban or any of the tablet ingredients.
• Contraindicated in patients with active clinically significant bleeding.
• Not recommended in patients with severe liver disease associated with coagulopathy and clinically relevant bleeding risk.
• Use with extreme caution in patients with kidney impairment; dose adjustment or alternative therapy may be required. Your doctor will evaluate kidney function before and during treatment.
• Increased risk of bleeding: Rivarospire can cause serious and potentially fatal bleeding. Inform your doctor about any history of bleeding disorders, stomach or intestinal ulcers, recent surgery, or trauma.
• Spinal/epidural procedures: Patients receiving neuraxial anesthesia (spinal/epidural) or undergoing spinal puncture are at risk of developing an epidural or spinal hematoma, which can result in long‑term or permanent paralysis. Inform your doctor and anesthesiologist if you are taking rivaroxaban.
• Drug interactions: Inform your doctor and pharmacist about all medicines you are taking, including other anticoagulants, antiplatelet drugs (such as aspirin, clopidogrel), NSAIDs, certain antifungals, antivirals, and herbal supplements (e.g., St. John’s wort), as they may increase bleeding risk or affect rivaroxaban levels.
• Pregnancy and breastfeeding: Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding. Anticoagulants may not be suitable in pregnancy unless clearly needed and under specialist supervision.
• Inform all healthcare providers and dentists that you are taking Rivarospire before any surgery, dental work, or invasive procedure.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include: easy bruising, nosebleeds, bleeding gums, heavier or prolonged menstrual bleeding, mild bleeding from cuts, or gastrointestinal symptoms such as stomach pain, indigestion, or nausea.
• Less common but serious side effects: severe or uncontrollable bleeding, blood in urine, black or tarry stools, coughing up or vomiting blood, severe headache, dizziness, weakness, sudden shortness of breath, chest pain, or signs of stroke (sudden numbness or weakness, trouble speaking, vision changes).
• Allergic reactions (rare): rash, itching, swelling of the face, lips, tongue, or throat, severe dizziness, or difficulty breathing. Seek immediate medical attention if these occur.
• Stop the medication and seek urgent medical help if you experience any signs of serious bleeding or stroke, or any sudden, severe, or unusual symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prescription anticoagulant medicine (direct factor Xa inhibitor).
• Strength: 20 mg rivaroxaban per film‑coated tablet.
• Form: Film‑coated tablets for oral use.
• Pack size: 28 tablets per pack.
• Intended users: Adults, as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.